The expectations that UCP1 could play a protective role in CV health were based on the collected experimental evidence and epidemiological reports, which demonstrated an inverse association between UCP1 transcription and insulin resistance, dyslipidemia and obesity [40]. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.